Bioartificial kidney under study at MCG
Whether a bioartificial kidney containing billions of donor kidney cells will help intensive care patients with kidney failure survive is under study at the Medical College of Georgia. MCG Medical Center has joined a study taking place in intensive care units across the country to evaluate the efficacy of the renal assist device, says Dr. Harold M. Szerlip, MCG nephrologist specializing i...Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
Deficiencies in the ability of cells to repair damaged DNA are associated with an increased risk of breast cancer, according to a new study in the January 19 issue of the Journal of the National Cancer Institute. is the system of defenses designed to protect the integrity of the genome. Studies have suggested that deficiency...Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine
When the most common adult leukemia in the United States was last reviewed by the New England Journal of Medicine (NEJM) in 1995, it was seen through the eyes of theories that dated back to the 1960s. As such, the journal recently invited three of the world's foremost experts on chronic lymphocytic leukemia (CLL) to write an authoritative update covering the transformation in the scientific commu...Iron Deficiency Sparks Dramatic Changes In Gene Expression
Researchers at Duke University Medical Centerhave demonstrated for the first time what happens inside a cell when itis deprived of the essential nutrient iron. Iron is found abundantly inred meats, shellfish dried fruits, whole grains, spinach, seeds andother foods.Their study in yeast cells demonstrated that iron-starved cellspreserve the little iron they possess by shutting down the major...Leukemia Drug Breakthrough Study In New England Journal Of Medicine
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia. Given in pill form, Revlimid simultaneously blocks the growth of new blood vessels th...Blasticidin S HCl from Invitrogen
Description:Blasticidin is a nucleoside antibiotic from Streptomyces griseochromogenes. It is a potent translational inhibitor in both prokaryotic and eukaryotic cells. Resistance to blasticidin is conferred by the products of the bsd gene product from Aspergillus terreus....Human TRAP 5 ImmunoCapture Assay Kit from BioVendor Laboratory Medicine, Inc.
Description:An immuncapture enzyme-activity assay based on measurenment of enzyme activity of TRAP 5 captured on monoclonal antibody coated microtiter plate. The procedure includes two incubation steps (1st standards, samples or controls, 2nd enzyme reaction) separated by a washing step. The assay is intended for the determination of human enzymaticaly active TRAP 5 (Tartrate Resistant Acid Phosphatase 5,...FRT flanked Ampicillin Selection Cassette (FRT-amp-FRT) from Gene Bridges GmbH
Description:The The prokaryotic promoter gb2 driving the gene for ampicillin resistance is a slightly modified version of the Em7 promoter. It mediates higher transcription efficiency than the generally used Tn5 promoter. A synthetic polyadenylation signal terminates the ampicillin expression. The cassette is flan...Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
midiprep kit Stratagene EF plasmid midiprep kit, a kit based on anion exchange chromatography, magneticbeads, and cesium ch...Highest Possible Transformation Efficiencies for High-Throughput Applications
Convenient, time-saving 96Pack Gold competent cells streamline transformation procedures Julie Bonnardel Ronda Allen Bruce Jerpseth Sean Banks...Efficiently Insert Unique Restriction Sites into Plasmid Vectors
Stratagene A 28-base insertion was introduced into a plasmid vector using theQuikChange site-directed mutagenesis kit.* Theinsertion created three unique restriction enzyme digestion sites. Plasmid DNAisolated from 9 o...Reliable Assessment of Micronuclei for Genotoxicity Testing in Mice or Rats
Reliable Assessment of Micronuclei for Genotoxicity Testing in Mice orRats Precise and cost-effective micronucleus analysis made easy with theicroFlow Micronucleus Analysis Kit Litron Laboratories, Rochester, NY Mark J. Dycaico<br...High-Efficiency Site-Directed Mutagenesis of Large Plasmid Vectors
QuikChange XL: a highly versatile kit for site-directed mutagenesis oflarge plasmids Michael Borns Peter Vaillancourt Holly Hogrefe Jeff Braman Stratagene The QuikChange site-directed mutagenesis kit* characteristicallygenerates mutagenesis efficiencies exceeding 80%. We have created a new kit formutagenesis of large plasmid...Nobel Prize for Medicine shared by Three scientists
Arvid Carlsson, Paul Greengard and Eric Kandel won the Nobel Prize in medicine for their discoveries concerning "signal transduction in the nervous system." The three Nobel laureates will share the 9 million kronor ($915,000) prize for their pioneering discoveries "concerning one type of signal transduction between nerve cells, referred to as slow synaptic transmission," according to the...Startling Expose – Physicians Often Have No Regular Source Of Health Car
Startling! But true! In a censure of the doctors around the world, a study conducted by researchers at the prestigious Yale and Johns Hopkins Universities has revealed that more than a third of physicians have no regular source of healthcare Dr. Cary P Gross of Yale University is New Haven, Connecticut says, ‘ these physicians without a regular source of health care are less likely than...Prince Charles lends support to Alternative Medicine
In an open show of support to Alternative Medicine, Britain's Prince Charles has urged the government to allocate 10 million pounds ($14.21 million) to fund a five-year research program into the effects of alternative medicine. The world is now sitting up and taking notice of holistic medicine and Prince Charles’s support to fund research in this field has come as a shot in the arm for th...Alternative medicine more popular among HIV positive patients
Despite significant improvements in anti AIDS therapy, complimentary and alternative medicine seem to be more attractive to the AIDS positive patients, according to a new study. Among 191 HIV-positive outpatients surveyed about their use of complementary and alternative therapies, 67% said they had used alternative therapies at some point to control their HIV infection and 40% reported cu...Pesticide impairs male reproductive function
According to the May issue of the journal Epidemiology, high levels of DDT found in some Mexican workers suggest that pesticide can impair male reproductive function. The human body metabolises DDT to DDE. An international team of researchers took blood samples from 24 men aged 16 to 28 who had not been exposed to DDT in their work. In these men the high DDE levels correlated to low leve...Centricity Cardiology- Image Management and Archive
Description:GE's complex Cath Lab solution enhances your productivity and workflow efficiency across your department, your facility and your entire enterprise....VERICIS Cardiovascular Information System
Description:Built on a single information technology platform, the VERICIS Cardiovascular Information System (CVIS) integrates data from different sites (office, clinic, hospital) and different sources (interventional and diagnostic x-ray angiography, echo, nuclear, MR, hemodynamics, reports, HIS) to create a comprehensive digital record on the cardiac patient. VERICIS empowers you to: <...Appendicitis: Evolving Tools to Diagnose a Classic Disease
Contributing Editor Appendicitis is a common, potentially lethal condition that affects 7% of individuals sometime in their lives. The condition occurs when the appendix, a blind pouch of intestine at the proximal colon, becomes obstructed by mucus, stool, or lymphatic tissue. Infection ensues, which can rapidly evol...Avexa's Apricitabine Clinical Trial Update
MELBOURNE, Australia--(BUSINESS WIRE)--Jul 5, 2007 - Australianbiotechnology company Avexa (ASX:AVX) announced today thecompletion of apricitabine's controlled, double blinded phase whichrepresents the first 24 week segment of its Phase IIb trial.Patients have now progressed into the open-label section of thetrial (weeks 24 to 48) and will continue to receive 800mgapricitabine twice a day a...Sexual orientation and medicine
<a href="/ ?q=/ Medicine-Definition/ Image:Portal_LGBT.svg" class="image" title="Portal:LGBT...